PETER ERIC OISHI

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow
    Peter E Oishi
    Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA
    Pediatr Res 73:54-61. 2013
  2. doi request reprint Pediatric pulmonary arterial hypertension: current and emerging therapeutic options
    Peter Oishi
    Cardiovascular Research Institute, Division of Critical Care Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 1346, USA
    Expert Opin Pharmacother 12:1845-64. 2011

Detail Information

Publications2

  1. pmc Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow
    Peter E Oishi
    Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA
    Pediatr Res 73:54-61. 2013
    ..Pulmonary vascular function is impaired with increased pulmonary blood flow (PBF). We hypothesized that a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist would mitigate this effect...
  2. doi request reprint Pediatric pulmonary arterial hypertension: current and emerging therapeutic options
    Peter Oishi
    Cardiovascular Research Institute, Division of Critical Care Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 1346, USA
    Expert Opin Pharmacother 12:1845-64. 2011
    ..An adequate understanding of the controlling pathophysiologic mechanisms is lacking and although mortality has decreased as therapeutic options have increased over the past several decades, outcomes remain unacceptable...